Remove Controlled Substances Remove Definition Remove FDA
article thumbnail

DEA Reaffirms Synthetic THC Compounds Are Schedule I Controlled Substances

The FDA Law Blog

Houck — The Drug Enforcement Administration’s (“DEA’s”) February 13th determination that THC acetate ester (“THCO”) is a schedule I controlled substance under the federal Controlled Substances Act (“CSA”) has received a good amount of attention in the cannabis press. By Larry K. 51639, 51641 (Aug.

article thumbnail

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

The FDA Law Blog

Palmer — The 2008 Ryan Haight Online Pharmacy Consumer Protection Act placed strict limits on online prescribing or the use of telemedicine encounters to prescribe controlled substances. The Act also established new definitions for “Internet,” “online pharmacy,” “practice of telemedicine,” among others. By Karla L. 21 U.S.C. §

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Long Strange Trip: Companion Bills Would Facilitate Psychedelics Research

The FDA Law Blog

Houck — Drugs and substances classified within schedule I of the federal Controlled Substances Act (“CSA”) by definition have a high potential for abuse, no currently accepted medical use in treatment in the United States, and lack accepted safety for use under medical supervision. By Larry K. 21 U.S.C. § 802(a) (7)(A)).

article thumbnail

FDA Takes Another Small Step to Increase Naloxone Access

The FDA Law Blog

In light of the urgent public health need to facilitate and expedite access to naloxone, FDA is implementing this Guidance immediately without prior public comment. Naloxone is a prescription drug, but unlike some other prescription drugs used in the treatment of opioid addiction such as buprenorphine , it is not a controlled substance.

FDA
article thumbnail

May 11, 2023: The End of the COVID-19 Pandemic Emergency’s DEA Telemedicine Exemption? “Not So Fast,” Say DEA and SAMHSA

The FDA Law Blog

Palmer — We blogged earlier this week here that DEA is reconsidering its proposed rules for telemedicine prescribing of controlled substances and buprenorphine. 802(54)(G) (which references CMS’s statutory definition of “practice of telemedicine”). By Karla L. 1307.41and 42 C.F.R. at 30,039 (emphasis added).

article thumbnail

DEA Regs Bulk Up with 2014 Anabolic Steroid Control Law Additions

The FDA Law Blog

Houck — Anabolic steroids that include testosterone, methyltestosterone, nandrolone decanoate and oxandrolone are schedule III controlled substances with currently accepted medical uses in the U.S. Implementation of the Designer Anabolic Steroid Control Act of 2014 , 88 Fed. By Larry K. 50,036 (Aug.

article thumbnail

Switching from Adderall to Vyvanse: Why and how to do it safely

The Checkup by Singlecare

Adderall ( amphetamine-dextroamphetamine ) and Vyvanse ( lisdexamfetamine dimesylate ) are both brand-name central nervous system (CNS) stimulants approved by the Food and Drug Administration (FDA) for the treatment of ADHD. Adderall is also FDA approved for narcolepsy, and Vyvanse is also FDA approved for binge eating disorder.

FDA